Denali Therapeutics Inc (DNLI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -256,000 | -128,447 | -512,540 | -383,991 | -257,089 |
| Depreciation Amortization | 3,710 | 1,586 | 930 | -294 | -1,215 |
| Accounts receivable | -3,927 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 4,102 | 3,875 | -7,520 | -4,112 | -43 |
| Other Working Capital | -27,114 | -27,496 | 149 | -4,867 | 1,354 |
| Other Operating Activity | 51,023 | 19,278 | 106,381 | 79,202 | 50,227 |
| Operating Cash Flow | $-228,206 | $-131,204 | $-412,600 | $-314,062 | $-206,766 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -3,271 | -2,466 | -9,502 | -7,978 | -9,356 |
| Purchase Of Investment | -394,579 | -123,074 | -441,263 | -188,555 | -137,926 |
| Sale Of Investment | 417,032 | 220,000 | 706,046 | 431,046 | 323,965 |
| Other Investing Activity | -28,800 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $-9,618 | $94,460 | $255,281 | $234,513 | $176,683 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -38 | -17 | -8,168 | -8,152 | -6,791 |
| Common Stock Issued | 21,700 | 19,061 | 8,459 | 5,235 | 4,652 |
| Other Financing Activity | 212,366 | 200,000 | 188,925 | 0 | 0 |
| Financing Cash Flow | $234,028 | $219,044 | $189,216 | $-2,917 | $-2,139 |
| Beginning Cash Position | 208,432 | 208,432 | 176,535 | 176,535 | 176,535 |
| End Cash Position | 204,636 | 390,732 | 208,432 | 94,069 | 144,313 |
| Net Cash Flow | $-3,796 | $182,300 | $31,897 | $-82,466 | $-32,222 |
| Free Cash Flow | |||||
| Operating Cash Flow | -228,206 | -131,204 | -412,600 | -314,062 | -206,766 |
| Capital Expenditure | -3,271 | -2,466 | -9,502 | -7,978 | -9,356 |
| Free Cash Flow | -231,477 | -133,670 | -422,102 | -322,040 | -216,122 |